TPP2 and immune system disorder: It has been reported that a mutation in tripeptidyl peptidase II (TPP2) or in phosphoinositide 3-kinase (PI3K), leads to TPP2 deficiency or activated PI3K, finally results in premature senescence of T cells and immunodeficiencies (68–70).